Vascular endothelial growth factor (VEGF)-targeting therapies for endocrine-refractory or -resistant metastatic breast cancer (MBC): Preliminary results of a systematic review and meta-analysis.


e11564 Background: Individual trial results of VEGF-targeting therapies in MBC are highly variable. METHODS This review was conducted according to a published protocol, following the guidelines of the Cochrane Collaboration. OBJECTIVE To assess the effect of VEGF-targeting therapies in addition to chemotherapy (ctx) in patients (pts) with MBC. Primary… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics